Literature DB >> 30108992

The role of aryl-topology in balancing between selective and dual 5-HT7R/5-HT1A actions of 3,5-substituted hydantoins.

Katarzyna Kucwaj-Brysz1, Rafał Kurczab2, Ewa Żesławska3, Annamaria Lubelska1, Małgorzata Anna Marć1, Gniewomir Latacz1, Grzegorz Satała2, Wojciech Nitek4, Katarzyna Kieć-Kononowicz1, Jadwiga Handzlik1.   

Abstract

In order to search for active and selective serotonin 5-HT7R antagonists among 3,5-disubstituted arylpiperazine-imidazolidine-2,4-diones, the role of the introduction/deletion and the mutual orientation of aromatic rings was analyzed. Chemical modifications of 2nd generation lead structure of 3-(3-(4-(diphenylmethyl)piperazin-1-yl)-2-hydroxypropyl)-5-(4-fluorophenyl)-5-methylimidazolidine-2,4-dione (2, KKB16) were performed. New derivatives (4-18) were designed and synthesized. X-ray crystallographic analysis of the representative compound 5-(4-fluorophenyl)-3-[2-hydroxy-3-(4-phenylpiperazin-1-yl)propyl]-5-methylimidazolidine-2,4-dione (3) was performed to support molecular modeling and SAR studies. The affinity for 5-HT7R, D2R and 5-HT1AR in radioligand binding assays for the entire series and ADME-Tox parameters in vitro for selected compounds (7, 10, and 13) were evaluated. Molecular docking and pharmacophore model assessment were performed. According to the obtained results, 5-methyl-5-naphthylhydantoin derivatives were found to be the new highly active 5-HT7R agents (Ki ≤ 5 nM) with significant selectivity over 5-HT1AR and D2R. On the contrary, the (1-naphthyl)piperazine moiety was gained with the potent dual 5-HT7R/5-HT1AR action (Ki: 11 nM/19 nM).

Entities:  

Year:  2018        PMID: 30108992      PMCID: PMC6072329          DOI: 10.1039/c8md00168e

Source DB:  PubMed          Journal:  Medchemcomm        ISSN: 2040-2503            Impact factor:   3.597


  29 in total

1.  Effect of the selective 5-HT7 receptor antagonist SB 269970 in animal models of anxiety and depression.

Authors:  Anna Wesołowska; Agnieszka Nikiforuk; Katarzyna Stachowicz; Ewa Tatarczyńska
Journal:  Neuropharmacology       Date:  2006-07-07       Impact factor: 5.250

2.  Synthesis and biological evaluation of 2-fluoro and 3-trifluoromethyl-phenyl-piperazinylalkyl derivatives of 1H-imidazo[2,1-f]purine-2,4(3H,8H)-dione as potential antidepressant agents.

Authors:  Agnieszka Zagórska; Adam Bucki; Marcin Kołaczkowski; Agata Siwek; Monika Głuch-Lutwin; Gabriela Starowicz; Grzegorz Kazek; Anna Partyka; Anna Wesołowska; Karolina Słoczyńska; Elżbieta Pękala; Maciej Pawłowski
Journal:  J Enzyme Inhib Med Chem       Date:  2016-06-29       Impact factor: 5.051

3.  Structure-activity relationships and molecular modeling studies of novel arylpiperazinylalkyl 2-benzoxazolones and 2-benzothiazolones as 5-HT(7) and 5-HT(1A) receptor ligands.

Authors:  Loredana Salerno; Valeria Pittalà; Maria N Modica; Maria A Siracusa; Sebastiano Intagliata; Alfredo Cagnotto; Mario Salmona; Rafał Kurczab; Andrzej J Bojarski; Giuseppe Romeo
Journal:  Eur J Med Chem       Date:  2014-08-07       Impact factor: 6.514

4.  Computer-aided insights into receptor-ligand interaction for novel 5-arylhydantoin derivatives as serotonin 5-HT7 receptor agents with antidepressant activity.

Authors:  Katarzyna Kucwaj-Brysz; Rafał Kurczab; Magdalena Jastrzębska-Więsek; Ewa Żesławska; Grzegorz Satała; Wojciech Nitek; Anna Partyka; Agata Siwek; Agnieszka Jankowska; Anna Wesołowska; Katarzyna Kieć-Kononowicz; Jadwiga Handzlik
Journal:  Eur J Med Chem       Date:  2018-02-01       Impact factor: 6.514

5.  MF-8, a novel promising arylpiperazine-hydantoin based 5-HT7 receptor antagonist: In vitro drug-likeness studies and in vivo pharmacological evaluation.

Authors:  Gniewomir Latacz; Annamaria Lubelska; Magdalena Jastrzębska-Więsek; Anna Partyka; Katarzyna Kucwaj-Brysz; Anna Wesołowska; Katarzyna Kieć-Kononowicz; Jadwiga Handzlik
Journal:  Bioorg Med Chem Lett       Date:  2018-02-03       Impact factor: 2.823

6.  Hydantoin derivatives as non-peptidic inhibitors of Ras farnesyl transferase.

Authors:  Jinho Lee; Jonghyun Kim; Jong Sung Koh; Hyun-Ho Chung; Kyoung-Hee Kim
Journal:  Bioorg Med Chem Lett       Date:  2006-01-25       Impact factor: 2.823

Review 7.  Dual- and triple-acting agents for treating core and co-morbid symptoms of major depression: novel concepts, new drugs.

Authors:  Mark J Millan
Journal:  Neurotherapeutics       Date:  2009-01       Impact factor: 7.620

8.  SAR-studies on the importance of aromatic ring topologies in search for selective 5-HT(7) receptor ligands among phenylpiperazine hydantoin derivatives.

Authors:  Jadwiga Handzlik; Andrzej J Bojarski; Grzegorz Satała; Monika Kubacka; Bassem Sadek; Abrar Ashoor; Agata Siwek; Małgorzata Więcek; Katarzyna Kucwaj; Barbara Filipek; Katarzyna Kieć-Kononowicz
Journal:  Eur J Med Chem       Date:  2014-03-18       Impact factor: 6.514

9.  Translational evaluation of JNJ-18038683, a 5-hydroxytryptamine type 7 receptor antagonist, on rapid eye movement sleep and in major depressive disorder.

Authors:  Pascal Bonaventure; Christine Dugovic; Michelle Kramer; Peter De Boer; Jaskaran Singh; Sue Wilson; Kirk Bertelsen; Jianing Di; Jonathan Shelton; Leah Aluisio; Lisa Dvorak; Ian Fraser; Brian Lord; Diane Nepomuceno; Abdellah Ahnaou; Wilhelmus Drinkenburg; Wenying Chai; Curt Dvorak; Steve Sands; Nicholas Carruthers; Timothy W Lovenberg
Journal:  J Pharmacol Exp Ther       Date:  2012-05-08       Impact factor: 4.030

10.  Effects of the selective 5-HT7 receptor antagonist SB-269970 and amisulpride on ketamine-induced schizophrenia-like deficits in rats.

Authors:  Agnieszka Nikiforuk; Tomasz Kos; Katarzyna Fijał; Małgorzata Hołuj; Dominik Rafa; Piotr Popik
Journal:  PLoS One       Date:  2013-06-11       Impact factor: 3.240

View more
  1 in total

1.  Synthesis, Docking Studies and Pharmacological Evaluation of Serotoninergic Ligands Containing a 5-Norbornene-2-Carboxamide Nucleus.

Authors:  Rosa Sparaco; Ewa Kędzierska; Agnieszka A Kaczor; Anna Bielenica; Elisa Magli; Beatrice Severino; Angela Corvino; Ewa Gibuła-Tarłowska; Jolanta H Kotlińska; Giorgia Andreozzi; Paolo Luciano; Elisa Perissutti; Francesco Frecentese; Marcello Casertano; Anna Leśniak; Magdalena Bujalska-Zadrożny; Małgorzata Oziębło; Raffaele Capasso; Vincenzo Santagada; Giuseppe Caliendo; Ferdinando Fiorino
Journal:  Molecules       Date:  2022-10-01       Impact factor: 4.927

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.